{"id":"https://openalex.org/W1997504565","doi":"https://doi.org/10.1002/(sici)1099-081x(199812)19:9<571::aid-bdd142>3.0.co;2-o","title":"Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat","display_name":"Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat","alternate_titles":[],"publication_year":1998,"publication_date":"1998-12-01","ids":{"openalex":"https://openalex.org/W1997504565","doi":"https://doi.org/10.1002/(sici)1099-081x(199812)19:9<571::aid-bdd142>3.0.co;2-o","mag":"1997504565","pmid":"https://pubmed.ncbi.nlm.nih.gov/9872338"},"language":"en","primary_location":{"id":"doi:10.1002/(sici)1099-081x(199812)19:9<571::aid-bdd142>3.0.co;2-o","doi":"https://doi.org/10.1002/(sici)1099-081x(199812)19:9<571::aid-bdd142>3.0.co;2-o","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1099-081x(199812)19:9<571::aid-bdd142>3.0.co;2-o","pdf_url":null,"source":{"id":"https://openalex.org/S57691945","display_name":"Biopharmaceutics & Drug Disposition","issn_l":"0142-2782","issn":["0142-2782","1099-081X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics &amp; Drug Disposition","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1997504565"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5106508494","display_name":"Yanfeng Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yanfeng Wang","raw_affiliation_strings":["Drug Metabolism and Pharmacokinetics Department, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Metabolism and Pharmacokinetics Department, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051196779","display_name":"Renee L. Aun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renee Aun","raw_affiliation_strings":["Drug Metabolism and Pharmacokinetics Department, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Metabolism and Pharmacokinetics Department, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005190976","display_name":"Francis L. S. Tse","orcid":"https://orcid.org/0000-0002-8742-4433","observed_orcids":["https://orcid.org/0000-0002-8742-4433"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francis L.S. Tse","raw_affiliation_strings":["Drug Metabolism and Pharmacokinetics Department, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Metabolism and Pharmacokinetics Department, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA","institution_ids":["https://openalex.org/I4210117619"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210117619"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":1.216,"has_fulltext":false,"cited_by_count":67,"citation_normalized_percentile":{"value":0.77307311,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"19","issue":"9","first_page":"571","last_page":"575"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.8276000022888184,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.8276000022888184,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.03929999843239784,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.019500000402331352,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brain-uptake","display_name":"brain uptake","score":0.8429999947547913},{"id":"https://openalex.org/keywords/blood-brain-barrier-permeability","display_name":"blood-brain barrier permeability","score":0.8420000076293945},{"id":"https://openalex.org/keywords/intranasal-administration","display_name":"intranasal administration","score":0.8659999966621399},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.8539999723434448},{"id":"https://openalex.org/keywords/olfactory-bulb","display_name":"olfactory bulb","score":0.902999997138977},{"id":"https://openalex.org/keywords/regional-brain-distribution","display_name":"brain regional distribution","score":0.5299999713897705},{"id":"https://openalex.org/keywords/tritium-labeled-drug","display_name":"tritium-labeled drug","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C2780496858","wikidata":"https://www.wikidata.org/wiki/Q644945","display_name":"Olfactory bulb","level":3,"score":0.7269228100776672},{"id":"https://openalex.org/C2781302852","wikidata":"https://www.wikidata.org/wiki/Q421336","display_name":"Dihydroergotamine","level":3,"score":0.724325954914093},{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.6351609826087952},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6244418025016785},{"id":"https://openalex.org/C2778801703","wikidata":"https://www.wikidata.org/wiki/Q156104","display_name":"Nasal cavity","level":2,"score":0.5697780847549438},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.49978017807006836},{"id":"https://openalex.org/C2777348757","wikidata":"https://www.wikidata.org/wiki/Q2346577","display_name":"Cortex (anatomy)","level":2,"score":0.43368491530418396},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3876269459724426},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.35739755630493164},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31759679317474365},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.3086121082305908},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29917198419570923},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20912781357765198},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10013765096664429},{"id":"https://openalex.org/C105702510","wikidata":"https://www.wikidata.org/wiki/Q514","display_name":"Anatomy","level":1,"score":0.09720703959465027},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.0},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000281","descriptor_name":"Administration, Intranasal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004087","descriptor_name":"Dihydroergotamine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014662","descriptor_name":"Vasoconstrictor Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/(sici)1099-081x(199812)19:9<571::aid-bdd142>3.0.co;2-o","doi":"https://doi.org/10.1002/(sici)1099-081x(199812)19:9<571::aid-bdd142>3.0.co;2-o","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1099-081x(199812)19:9<571::aid-bdd142>3.0.co;2-o","pdf_url":null,"source":{"id":"https://openalex.org/S57691945","display_name":"Biopharmaceutics & Drug Disposition","issn_l":"0142-2782","issn":["0142-2782","1099-081X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics &amp; Drug Disposition","raw_type":"journal-article"},{"id":"pmid:9872338","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9872338","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & drug disposition","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W86815436","https://openalex.org/W2909865151","https://openalex.org/W2093548899","https://openalex.org/W1975983683","https://openalex.org/W2081927937","https://openalex.org/W1968427961","https://openalex.org/W2058971551","https://openalex.org/W2094834305","https://openalex.org/W2095379992","https://openalex.org/W2027376257"],"abstract_inverted_index":{"This":[0],"study":[1],"was":[2,95,129,207,271,295],"conducted":[3],"to":[4,120,127,186,216,239,254,297,320],"determine":[5],"the":[6,12,99,105,108,133,162,200,236,240,245,264,269,286,299,303,307,314],"uptake":[7],"of":[8,35,135,169,179,313],"dihydroergotamine":[9,38],"(DHE)":[10],"into":[11,161],"brain":[13,67,81,101,128,138,163,195,246,300],"after":[14],"intravenous":[15,27,289],"and":[16,62,65,80,104,141,149,211,227],"intranasal":[17,32],"administration":[18],"in":[19,51,63,137,193,204,212,267],"rats.":[20],"Eight":[21],"anesthetized":[22],"rats":[23],"received":[24],"either":[25],"an":[26,92,156,259,279],"(i.v.)":[28],"or":[29],"two":[30],"successive":[31],"(i.n.)":[33],"doses":[34,199],"tritium":[36],"labeled":[37],"(3H-DHE)":[39],"with":[40,164,306],"14C-inulin":[41],"as":[42],"a":[43,165,231,243,311],"non-BBB":[44],"(blood-brain":[45],"barrier)":[46],"permeable":[47],"marker.":[48],"Radioactivity":[49],"concentrations":[50,248],"plasma":[52,109,119,145,228],"were":[53,252],"determined":[54,139,202],"at":[55,83,172,249],"designated":[56],"times":[57,274],"within":[58],"30":[59,84,173,250],"min":[60,174,251],"postdose,":[61],"blood":[64],"seven":[66,217],"regions":[68,214],"(olfactory":[69],"bulb,":[70,266],"frontal":[71],"cortex,":[72,74,76],"parietal":[73],"occipital":[75],"cerebellum,":[77],"mid-brain":[78],"areas,":[79],"stem)":[82],"min.":[85],"The":[86,176],"plasma-to-brain":[87],"permeability*area":[88],"product":[89],"(PeA)":[90],"following":[91,258,278,288],"i.v.":[93,153,157,260,280],"dose":[94,261],"calculated":[96],"based":[97,131,143,223],"on":[98,132,144,225],"30-min":[100],"tissue":[102,247],"concentration":[103,167,203,270],"area":[106],"under":[107],"concentration-time":[110],"curve":[111],"(AUC0-30":[112],"min,":[113,147],"i.v.)":[114],"assuming":[115],"unidirectional":[116],"transport":[117,123,233],"from":[118,124,152,182,235,302,317],"brain.":[121,241,321],"Direct":[122],"nasal":[125,237,304,318],"cavity":[126,238,319],"assessed":[130],"amount":[134],"radioactivity":[136],"experimentally":[140,201],"predicted":[142,221],"AUC0-30":[146],"i.n.":[148,198,292],"PeA":[150,177,226],"obtained":[151],"data.":[154],"Following":[155,197,291],"dose,":[158],"DHE":[159,180],"distributed":[160],"brain-to-plasma":[166],"ratio":[168],"approximately":[170,208,272],"5%":[171],"postdose.":[175],"value":[178],"ranged":[181],"8.6":[183],"x":[184,188],"10(-4)":[185,189],"37.5":[187],"mL":[190],"min(-1)":[191],"g(-1)":[192],"different":[194],"regions.":[196],"olfactory":[205,265,308],"bulb":[206,309],"51":[209],"times,":[210,218],"other":[213],"three":[215],"greater":[219,275],"than":[220,276],"values":[222],"only":[224],"AUC,":[229],"suggesting":[230],"direct":[232,315],"pathway":[234],"As":[242],"result,":[244],"similar":[253],"(0.31-1.04":[255],"times)":[256],"those":[257],"except":[262],"for":[263],"which":[268],"four":[273],"that":[277],"dose.":[281],"In":[282],"conclusion,":[283],"3H-DHE":[284,294],"penetrated":[285],"BBB":[287],"administration.":[290],"doses,":[293],"able":[296],"enter":[298],"directly":[301],"cavity,":[305],"being":[310],"part":[312],"passage":[316]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1997504565","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
